Patents by Inventor Jacob Berger

Jacob Berger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12683893
    Abstract: Methods and systems for routing messages based on message priority. In some aspects, the system may determine paths between a source and one or more destinations. The system may determine, for a first message, using a machine learning model, a first predicted path having a first distance. The system may determine, based on the first predicted path, using a Markov decision process, a priority of the first message. Based on determining that a first confidence score for the first predicted path does not exceed a threshold, the system may select a different path for the first message. The system may select the different path based on the priority of the first message and a second distance associated with the different path. The system may then re-direct the first message along the different path.
    Type: Grant
    Filed: August 5, 2024
    Date of Patent: July 14, 2026
    Assignee: Capital One Services, LLC
    Inventors: Jacob Berger, Charles DeVore, Xiaoyi Wang, Lindsey May, Waleed Algadhi, Linsu Han
  • Patent number: 12545913
    Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods provide signal boost upon detection of target nucleic acids of interest in less than one minute and in some instances instantaneously at ambient temperatures down to 16° C. or less, without amplification of the target nucleic acids yet allowing for massive multiplexing, high accuracy and minimal non-specific signal generation.
    Type: Grant
    Filed: August 16, 2023
    Date of Patent: February 10, 2026
    Assignee: VedaBio, Inc.
    Inventors: Anurup Ganguli, Ashish Pandey, Ariana Mostafa, Jacob Berger
  • Publication number: 20260039585
    Abstract: Methods and systems for routing messages based on message priority. In some aspects, the system may determine paths between a source and one or more destinations. The system may determine, for a first message, using a machine learning model, a first predicted path having a first distance. The system may determine, based on the first predicted path, using a Markov decision process, a priority of the first message. Based on determining that a first confidence score for the first predicted path does not exceed a threshold, the system may select a different path for the first message. The system may select the different path based on the priority of the first message and a second distance associated with the different path. The system may then re-direct the first message along the different path.
    Type: Application
    Filed: August 5, 2024
    Publication date: February 5, 2026
    Applicant: Capital One Services, LLC
    Inventors: Jacob BERGER, Charles DeVORE, Xiaoyi WANG, Lindsey MAY, Waleed ALGADHI, Linsu HAN
  • Publication number: 20250382663
    Abstract: Presented is a nucleic acid-guided nuclease cascade assay that can detect one or more target nucleic acids of interest of interest without the need for amplifying the target nucleic acids of interest. The nucleic acid-guided nuclease cascade assays utilize signal amplification mechanisms comprising various components including nucleic acid-guided nucleases and guide RNAs (gRNAs) forming ribonucleoprotein complexes, blocked primer molecules, template molecules, polymerases and reporter moieties.
    Type: Application
    Filed: August 29, 2025
    Publication date: December 18, 2025
    Inventors: Ashish Pandey, Anurup Ganguli, Ariana Mostafa, Jacob Berger
  • Patent number: 12410464
    Abstract: Presented is a nucleic acid-guided nuclease cascade assay that can detect one or more target nucleic acids of interest of interest without the need for amplifying the target nucleic acids of interest. The nucleic acid-guided nuclease cascade assays utilize signal amplification mechanisms comprising various components including nucleic acid-guided nucleases and guide RNAs (gRNAs) forming ribonucleoprotein complexes, blocked primer molecules, template molecules, polymerases and reporter moieties.
    Type: Grant
    Filed: February 25, 2024
    Date of Patent: September 9, 2025
    Assignee: VedaBio, Inc.
    Inventors: Ashish Pandey, Anurup Ganguli, Ariana Mostafa, Jacob Berger
  • Publication number: 20250215428
    Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods allow one to control reaction kinetics of the cascade assay by two orders of magnitude via molecular design of one of the reaction components; further, varying molecular design also allows for quantification of target nucleic acids of interest over a large range of concentrations or discriminating between extremely low copy numbers of target nucleic acids of interest.
    Type: Application
    Filed: January 31, 2025
    Publication date: July 3, 2025
    Inventors: Jacob Berger, Ashish Pandey, Ariana Mostafa, Anurup Ganguli
  • Publication number: 20250109399
    Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods provide signal boost upon detection of target nucleic acids of interest in less than one minute and in some instances instantaneously at ambient temperatures down to 16° C. or less, without amplification of the target nucleic acids yet allowing for massive multiplexing, high accuracy and minimal non-specific signal generation.
    Type: Application
    Filed: September 16, 2024
    Publication date: April 3, 2025
    Inventors: Anurup Ganguli, Ashish Pandey, Ariana Mostafa, Jacob Berger
  • Patent number: 12247205
    Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods allow one to control reaction kinetics of the cascade assay by two orders of magnitude via molecular design of one of the reaction components; further, varying molecular design also allows for quantification of target nucleic acids of interest over a large range of concentrations or discriminating between extremely low copy numbers of target nucleic acids of interest.
    Type: Grant
    Filed: August 15, 2024
    Date of Patent: March 11, 2025
    Assignee: VedaBio, Inc.
    Inventors: Ashish Pandey, Ariana Mostafa, Jacob Berger, Anurup Ganguli
  • Publication number: 20240401051
    Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods allow one to control reaction kinetics of the cascade assay by two orders of magnitude via molecular design of one of the reaction components; further, varying molecular design also allows for quantification of target nucleic acids of interest over a large range of concentrations or discriminating between extremely low copy numbers of target nucleic acids of interest.
    Type: Application
    Filed: August 15, 2024
    Publication date: December 5, 2024
    Inventors: Ashish Pandey, Ariana Mostafa, Jacob Berger, Anurup Ganguli
  • Patent number: 12129468
    Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods provide signal boost upon detection of target nucleic acids of interest in less than one minute and in some instances instantaneously at ambient temperatures down to 16° C. or less, without amplification of the target nucleic acids yet allowing for massive multiplexing, high accuracy and minimal non-specific signal generation.
    Type: Grant
    Filed: January 31, 2024
    Date of Patent: October 29, 2024
    Assignee: VedaBio, Inc.
    Inventors: Anurup Ganguli, Ashish Pandey, Ariana Mostafa, Jacob Berger
  • Patent number: 12104158
    Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods allow one to control reaction kinetics of the cascade assay by two orders of magnitude via molecular design of one of the reaction components; further, varying molecular design also allows for quantification of target nucleic acids of interest over a large range of concentrations or discriminating between extremely low copy numbers of target nucleic acids of interest.
    Type: Grant
    Filed: February 23, 2024
    Date of Patent: October 1, 2024
    Assignee: VedaBio, Inc.
    Inventors: Ashish Pandey, Ariana Mostafa, Jacob Berger, Anurup Ganguli
  • Publication number: 20240218428
    Abstract: The present disclosure describes compositions of matter comprising a ribonucleoprotein complex comprising a nucleic acid-guided nuclease and a guide RNA, and further comprising a blocking nucleic acid molecule represented by Formula IV, wherein Formula IV in the 5?-to-3? direction comprises: T-D-M-A-Lp-C; wherein T is 17-31 nucleotides in length; D is 0-15 nucleotides in length; M is 1-25 nucleotides in length; A is 0-15 nucleotides in length and comprises a sequence complementary to D; and L is 3-25 nucleotides in length; p is 0 or 1; C is 4-15 nucleotides in length and comprises a sequence complementary to T; and wherein the blocking nucleic acid molecule comprises a sequence complementary to a gRNA.
    Type: Application
    Filed: February 25, 2024
    Publication date: July 4, 2024
    Inventors: Ashish Pandey, Anurup Ganguli, Ariana Mostafa, Jacob Berger
  • Publication number: 20240218364
    Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods provide signal boost upon detection of target nucleic acids of interest in less than one minute and in some instances instantaneously at ambient temperatures down to 16° ° C. or less, without amplification of the target nucleic acids yet allowing for massive multiplexing, high accuracy and minimal non-specific signal generation.
    Type: Application
    Filed: January 31, 2024
    Publication date: July 4, 2024
    Inventors: Anurup Ganguli, Ashish Pandey, Ariana Mostafa, Jacob Berger
  • Publication number: 20240191234
    Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods allow one to control reaction kinetics of the cascade assay by two orders of magnitude via molecular design of one of the reaction components; further, varying molecular design also allows for quantification of target nucleic acids of interest over a large range of concentrations or discriminating between extremely low copy numbers of target nucleic acids of interest.
    Type: Application
    Filed: February 23, 2024
    Publication date: June 13, 2024
    Inventors: Ashish Pandey, Ariana Mostafa, Jacob Berger, Anurup Ganguli
  • Patent number: 11987839
    Abstract: The present disclosure describes compositions of matter comprising a ribonucleoprotein complex comprising a nucleic acid-guided nuclease and a guide RNA, and further comprising a blocking nucleic acid molecule represented by Formula IV, wherein Formula IV in the 5?-to-3? direction comprises: T-D-M-A-Lp-C; wherein T is 17-31 nucleotides in length; D is 0-15 nucleotides in length; M is 1-25 nucleotides in length; A is 0-15 nucleotides in length and comprises a sequence complementary to D; and L is 3-25 nucleotides in length; p is 0 or 1; C is 4-15 nucleotides in length and comprises a sequence complementary to T; and wherein the blocking nucleic acid molecule comprises a sequence complementary to a gRNA.
    Type: Grant
    Filed: September 24, 2023
    Date of Patent: May 21, 2024
    Assignees: VedaBio, Inc., The Board of Trustees of The University of Illinois
    Inventors: Anurup Ganguli, Ariana Mostafa, Jacob Berger, Ashish Pandey
  • Patent number: 11970730
    Abstract: The present disclosure describes compositions of matter comprising a ribonucleoprotein complex comprising a nucleic acid-guided nuclease and a guide RNA, and further comprising and a blocking nucleic acid molecule represented by Formula III in the 5?-to-3? direction comprises: T-D-M-A-(B-L)J-C; wherein T is 17-135 nucleotides in length; D is 0-10 nucleotides in length; M is 1-25 nucleotides in length or is absent, wherein if M is absent then T-D and A-(B-L)J-C are separate nucleic acid strands; A is 0-15 nucleotides in length and comprises at least 50% sequence complementarity to D; B is 4-12 nucleotides in length and comprises at least 50% sequence complementarity to T; L is 3-25 nucleotides in length; J is an integer between 1 and 10; C is 4-15 nucleotides in length; and wherein the blocking nucleic acid molecule comprises a sequence complementary to a gRNA.
    Type: Grant
    Filed: June 10, 2023
    Date of Patent: April 30, 2024
    Assignee: VedaBio, Inc.
    Inventors: Anurup Ganguli, Ariana Mostafa, Jacob Berger, Ashish Pandey, Rashid Bashir
  • Publication number: 20240110251
    Abstract: Described herein are systems and methods which utilize an array of wells to rapidly detect target analytes from whole blood samples, even at very low concentrations. The provided systems and methods dry the blood sample to ensure a fluidic network forms in one or more dry blood sample islands and liquid with reagents useful for detecting nucleic acid sequences from a target analyte, including by amplification reactions that are bi-phasic because of the interaction between the solid dried blood sample phase and the liquid phases, including liquid having reagents that are able to fluidically and diffusively exchange with the fluidic network within the dried blood sample phase.
    Type: Application
    Filed: September 25, 2023
    Publication date: April 4, 2024
    Inventors: Rashid BASHIR, Anurup Ganguli, Jongwon Lim, Ariana Mostafa, Enrique Andres Valera Cano, Matthew Wester, Jacob Berger
  • Patent number: 11946052
    Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods allow one to control reaction kinetics of the cascade assay by two orders of magnitude via molecular design of one of the reaction components; further, varying molecular design also allows for quantification of target nucleic acids of interest over a large range of concentrations or discriminating between extremely low copy numbers of target nucleic acids of interest.
    Type: Grant
    Filed: November 24, 2023
    Date of Patent: April 2, 2024
    Assignee: VedaBio, Inc.
    Inventors: Ariana Mostafa, Jacob Berger, Ashish Pandey, Anurup Ganguli
  • Publication number: 20240102014
    Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods allow one to control reaction kinetics of the cascade assay by two orders of magnitude via molecular design of one of the reaction components; further, varying molecular design also allows for quantification of target nucleic acids of interest over a large range of concentrations or discriminating between extremely low copy numbers of target nucleic acids of interest.
    Type: Application
    Filed: November 24, 2023
    Publication date: March 28, 2024
    Inventors: Ariana Mostafa, Jacob Berger, Ashish Pandey, Anurup Ganguli
  • Publication number: 20240035028
    Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods provide signal boost upon detection of target nucleic acids of interest in less than one minute and in some instances instantaneously at ambient temperatures down to 16° C. or less, without amplification of the target nucleic acids yet allowing for massive multiplexing, high accuracy and minimal non-specific signal generation.
    Type: Application
    Filed: August 16, 2023
    Publication date: February 1, 2024
    Inventors: Anurup Ganguli, Ashish Pandey, Ariana Mostafa, Jacob Berger